G01N 33/5047
Cells of the immune system
Official title: {Cells of the immune system}
G01N33/5047 (Cells of the immune system) appears on 1,647 US grants and 3,546 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,647
- Published applications
- 3,546
- Assignees
- 1,260
- Inventors
- 5,605
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 7 | 0 |
| 1997 | 8 | 0 |
| 1998 | 26 | 0 |
| 1999 | 26 | 0 |
| 2000 | 16 | 0 |
| 2001 | 18 | 11 |
| 2002 | 24 | 59 |
| 2003 | 23 | 517 |
| 2004 | 20 | 130 |
| 2005 | 17 | 114 |
| 2006 | 51 | 112 |
| 2007 | 91 | 95 |
| 2008 | 98 | 81 |
| 2009 | 46 | 107 |
| 2010 | 60 | 124 |
| 2011 | 44 | 99 |
| 2012 | 50 | 127 |
| 2013 | 56 | 100 |
| 2014 | 51 | 91 |
| 2015 | 71 | 137 |
| 2016 | 61 | 148 |
| 2017 | 69 | 145 |
| 2018 | 97 | 136 |
| 2019 | 84 | 146 |
| 2020 | 82 | 181 |
| 2021 | 93 | 196 |
| 2022 | 81 | 182 |
| 2023 | 78 | 150 |
| 2024 | 77 | 154 |
| 2025 | 68 | 131 |
| 2026 | 48 | 73 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- FOXM1-derived peptide, and vaccine including same29 Sep 2026US 12,747,265 B2Oncotherapy Science, Inc.
- Method and system for detecting cell-killing efficacy and/or immune activity, and application thereof8 Sep 2026US 12,730,104 B2Shanghai Ruiyu Biotech Co., Ltd.
- Modulation of splenocytes in cell therapy1 Sep 2026US RE51,018 E1Board of Regents, The University of Texas System
- HIV immunotherapy with no pre-immunization step18 Aug 2026US 12,709,753 B2American Gene Technologies International Inc.
- Method of assessing activity of recombinant antigen receptors11 Aug 2026US 12,703,734 B2Juno Therapeutics, Inc.
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
- Prediction of immunostimulatory potential of aav in a human preclinical model8 Oct 2026US 2026/0309699 A1
- Ligand discovery and gene delivery via retroviral surface display8 Oct 2026US 2026/0309700 A1Massachusetts Institute of Technology
- Compositions and methods for determining the effects of t cell engager8 Oct 2026US 2026/0309708 A1Arbele Limited
Most cited
By later US patents
- Miniaturized cell array methods and apparatus for cell-based screening303US 6,103,479 ACellomics, Inc. · 2000
- Human secreted proteins202US 7,368,531 B2Human Genome Sciences, Inc. · 2008
- Miniaturized cell array methods and apparatus for cell-based screening177US 6,548,263 B1Cellomics, Inc. · 2003
- Tolerogenic synthetic nanocarriers for inducing regulatory B cells129US 8,652,487 B2Selecta Biosciences, Inc. · 2014
- G-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereof125US 5,939,320 ANew York University · 1999